Zydus Lifesciences' Ambernath API Facility Passes US FDA Inspection with Zero Observations

Unknown Apr 02, 2026 950 Views

Zydus Lifesciences Ltd has passed a US Food and Drug Administration (FDA) surveillance inspection at its active pharmaceutical ingredient (API) manufacturing facility in Ambernath, Maharashtra. The February 10-14, 2025, inspection ended with zero observations, affirming Zydus' dedication to q...